This company listing is no longer active
MDC Stock Overview
Designs, manufactures, and supplies medical products and hospital equipment in Italy and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Medica S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €29.80 |
| 52 Week High | €30.00 |
| 52 Week Low | €14.40 |
| Beta | -0.022 |
| 1 Month Change | 8.76% |
| 3 Month Change | 12.88% |
| 1 Year Change | 37.96% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -10.91% |
Recent News & Updates
Risks To Shareholder Returns Are Elevated At These Prices For Medica S.p.A. (BIT:MDC)
Apr 06
Returns On Capital Signal Tricky Times Ahead For Medica (BIT:MDC)
Feb 05Shareholder Returns
| MDC | IT Medical Equipment | IT Market | |
|---|---|---|---|
| 7D | 0% | -2.8% | -2.8% |
| 1Y | 38.0% | 7.9% | 8.5% |
Return vs Industry: MDC exceeded the Italian Medical Equipment industry which returned 7.3% over the past year.
Return vs Market: MDC exceeded the Italian Market which returned 10.8% over the past year.
Price Volatility
| MDC volatility | |
|---|---|
| MDC Average Weekly Movement | 3.2% |
| Medical Equipment Industry Average Movement | 5.0% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in IT Market | 7.8% |
| 10% least volatile stocks in IT Market | 2.5% |
Stable Share Price: MDC has not had significant price volatility in the past 3 months.
Volatility Over Time: MDC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 696 | Marco Fecondini | www.medica.it |
Medica S.p.A., together with its subsidiaries, designs, manufactures, and supplies medical products and hospital equipment in Italy and internationally. It offers blood purification equipment comprising dialyzers, ultrafilters, HDF on line sets, blood lines, and pediatric dialyzers for dialysis treatment; and critical care CRRT equipment, hemofilters, pediatric filters, C02 removal, apheresis equipment, fractionator for cascade filtration, plasma filters, and leukocyte adsorber. The company also provides Cardiosmart, an integrated system for the treatment of patients affected by congestive heart failure; MediSulfone membrane and Purema hemoconcentrators for cardiosurgery; and VETSmart, a system to perform hemofiltration, dialysis, and plasmafiltration therapies; and ProtSmart.
Medica S.p.A. Fundamentals Summary
| MDC fundamental statistics | |
|---|---|
| Market cap | €125.85m |
| Earnings (TTM) | €2.97m |
| Revenue (TTM) | €81.58m |
42.4x
P/E Ratio1.5x
P/S RatioIs MDC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDC income statement (TTM) | |
|---|---|
| Revenue | €81.58m |
| Cost of Revenue | €49.40m |
| Gross Profit | €32.18m |
| Other Expenses | €29.21m |
| Earnings | €2.97m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.70 |
| Gross Margin | 39.44% |
| Net Profit Margin | 3.64% |
| Debt/Equity Ratio | 48.1% |
How did MDC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/08/15 07:50 |
| End of Day Share Price | 2024/08/15 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medica S.p.A. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Luca Arena | CFO SIM S.p.A. |
| Manuela Meroni | Intesa Sanpaolo Equity Research |